Estarylla is technically a low-dose birth control pill, but it sits at the higher end of that category. Each active tablet contains 35 micrograms (mcg) of ethinyl estradiol, which falls below the 50 mcg cutoff that defines “low dose” in clinical practice. However, many newer pills contain just 20 mcg or even 10 mcg of estrogen, so Estarylla delivers noticeably more estrogen than the lowest options available today.
What “Low Dose” Actually Means
In medical terms, any combined birth control pill with less than 50 mcg of ethinyl estradiol counts as low dose. Pills with 50 mcg are older formulations now reserved mainly for treating heavy uterine bleeding, not everyday contraception. By this standard, Estarylla’s 35 mcg qualifies as low dose.
But the category has gotten wider over the years. Current pills come in several estrogen tiers: 35 mcg, 30 mcg, 25 mcg, 20 mcg, and now even 10 mcg. Some clinicians informally call 20 mcg pills “ultra-low dose” to distinguish them from 35 mcg formulations like Estarylla. So while Estarylla meets the clinical definition of low dose, it contains roughly 75% more estrogen than a 20 mcg pill. If you came across someone describing their pill as “low dose” and they’re taking a 20 mcg version, that’s a meaningfully different amount of estrogen than what’s in Estarylla.
What’s in Each Estarylla Tablet
Each pack of Estarylla contains 21 active blue tablets and 7 inactive green tablets. Every active tablet delivers 0.25 mg of norgestimate (the progestin) and 0.035 mg of ethinyl estradiol (the estrogen). It’s a monophasic pill, meaning every active tablet has the same hormone levels rather than changing doses throughout the cycle.
Estarylla is a generic version of Ortho-Cyclen and shares identical active ingredients with Sprintec, Mili, and Mono-Linyah. If you’ve taken any of those, you’ve taken the same formulation.
Why the Estrogen Level Matters
The amount of estrogen in your pill affects both side effects and certain health risks. Higher estrogen levels are more likely to cause nausea, bloating, breast tenderness, headaches, and fluid retention in the ankles or feet. These effects tend to be dose-dependent, meaning a 35 mcg pill may produce more of them than a 20 mcg pill.
On the risk side, clinical guidelines note that pills with 20 mcg of estrogen likely carry slightly less cardiovascular and blood clot risk than 35 mcg pills, though the data isn’t strong enough to make a definitive safety distinction between the two. Current recommendations from UpToDate suggest that it makes sense to start with a 20 mcg pill and increase only if spotting becomes a problem. That said, all pills under 50 mcg are considered safe and reliable for the vast majority of women.
The tradeoff is that lower estrogen pills tend to cause more breakthrough bleeding, especially in the first few months. Estarylla’s 35 mcg dose generally provides better cycle control than 20 mcg options, which is one reason it remains widely prescribed.
Common Side Effects at 35 mcg
The most frequently reported side effects of Estarylla include nausea, vomiting, headache, bloating, breast tenderness, fluid retention, and weight changes. Spotting or irregular bleeding between periods is also common, particularly during the first one to three packs. These symptoms typically resolve on their own without stopping the pill.
If spotting persists beyond three months, that’s worth discussing with your prescriber. But for most people, the adjustment period is temporary. With perfect use, Estarylla’s failure rate is less than 1% per year. With typical use (accounting for missed pills and human error), effectiveness drops to about 91% to 93%.
Who Might Want a Lower Estrogen Option
For most healthy people, a 35 mcg pill like Estarylla works well. But certain factors can tip the balance toward choosing a pill with less estrogen. Age is an independent risk factor for cardiovascular problems and blood clots, so perimenopausal women, especially those who also have obesity, diabetes, or high blood pressure, are generally advised to avoid estrogen-containing contraception or choose the lowest effective dose. Pills with 10 mcg of ethinyl estradiol are now available and can be a good fit for this group.
If you’re experiencing side effects that seem estrogen-related (persistent nausea, significant bloating, breast pain), switching to a 20 mcg or 25 mcg formulation may help. Conversely, if you started on a lower-dose pill and struggled with persistent spotting, moving up to Estarylla’s 35 mcg can often resolve it. The “right” dose is ultimately whichever one balances cycle control, side effects, and your individual risk profile.